Medicine and Dentistry
Interferon
100%
Phase II Trials
100%
Kidney Metastasis
100%
Interleukin 2
100%
Isotretinoin
100%
Patient
100%
Inpatient
100%
Toxicity
23%
Outpatient
15%
Combination Therapy
15%
Lung
15%
Survival
15%
Diseases
7%
Surgery
7%
Immunotherapy
7%
Metastatic Carcinoma
7%
Cardiomyopathy
7%
Informed Consent
7%
Hyperlipidemia
7%
Nausea and Vomiting
7%
Flu Like Syndrome
7%
Fatigue
7%
Soft Tissue Metastasis
7%
Patient History of Nephrectomy
7%
Death
7%
Organ
7%
INIS
patients
100%
kidneys
100%
metastases
100%
interleukins
100%
interferon
100%
retinoic acid
100%
carcinomas
100%
toxicity
21%
therapy
14%
diseases
14%
performance
14%
lungs
14%
tissues
7%
surgery
7%
organs
7%
death
7%
immunotherapy
7%
symptoms
7%
fatigue
7%
nausea
7%
vomiting
7%
nephrectomy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Interleukin 2
100%
Kidney Metastasis
100%
Isotretinoin
100%
Toxicity
75%
Survival
50%
Diseases
25%
Nausea and Vomiting
25%
Immunotherapy
25%
Metastasis
25%
Flu Like Syndrome
25%
Hyperlipidemia
25%
Death
25%
Soft Tissue Metastasis
25%
Cardiomyopathy
25%
Patient History of Nephrectomy
25%
Fatigue
25%
Nursing and Health Professions
Interferon
100%
Isotretinoin
100%
Kidney Metastasis
100%
Interleukin 2
100%
Toxicity
23%
Combination Therapy
15%
Survival
15%
Diseases
7%
Surgery
7%
Metastasis
7%
Immunotherapy
7%
Nausea and Vomiting
7%
Cardiomyopathy
7%
Flu Like Syndrome
7%
Hyperlipidemia
7%
Fatigue
7%
Death
7%
Soft Tissue Metastasis
7%
Patient History of Nephrectomy
7%